[Stock of the Day] GC Genome, a Genetic Analysis Play, and Hanmi Pharm, Maker of a Domestic Obesity Drug, in Focus
Predicted impact: Low
Daily stock-pick mention with no company-specific facts or sizes given.
GC Genome지씨지놈
340450 · KOSDAQ · ₩340450 · 지씨지놈
₩8,580▲ ₩140 (1.66%)End-of-day · Oct 29, 2026 · End-of-day prices.
GC Genome plans US commercialization of pancreatic cancer test next year, "expects recovery of offering price" [Why Bio]
Predicted impact: Low
Planned US commercialization of cancer test next year; small, vague timeline.
GC Genome shares surge as it expands into US and Japan with AI blood test
Predicted impact: Medium
AI blood test expansion into US and Japan; no sales size given, revenue base small.
[Yeouido Investment Division 1] 'SK Hynix, GC Genome' - which stocks will make the Hall of Fame?
Predicted impact: Low· Actual: 0.0% vs sector, volume 1.2× normal (5 trading days)
Stock-picking TV segment with no new company facts; similar market chatter already appeared recently.
Also known as: GC Genome / 지씨지놈 / 340450 / KRX:340450
Source: KRX statistical information